Abbott Laboratories (ABT) vs Koninklijke Philips N.V. (PHG)
- Abbott Laboratories ABT 110.37 −2.84%
- Koninklijke Philips N.V. PHG 30.32 −0.62%
Abbott Laboratories and Koninklijke Philips N.V. are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $29.8B — 6.6× the size. Koninklijke Philips N.V. trades at the lower P/E: 25.8× against 42.3×. Abbott Laboratories grew revenue faster over the last twelve months: 10.0% against 7.98%. Abbott Laboratories has the higher net margin (9.75% vs 5.34%) and the lower return on invested capital (0.00% vs 6.15%). Both pay a dividend; Koninklijke Philips N.V. yields more (3.33% vs 2.22%). Across the 23 metrics below, Koninklijke Philips N.V. leads on 15 and Abbott Laboratories on 8.
Valuation
Profitability
| Metric | ABT | PHG | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 46.43% | 57.76% |
| Operating margin | 13.78% | 8.68% | (15.07%) |
| Net margin | 9.75% | 5.34% | (14.45%) |
| Free cash flow margin | 0.00% | 10.27% | (3.88%) |
| Return on equity | 0.00% | 8.54% | (10.35%) |
| Return on assets | 0.00% | 3.49% | (17.26%) |
| Return on invested capital | 0.00% | 6.15% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack